Neurovascular Devices Market by Disease Pathology, End User - Global Forecast to 2030

1.1 Study Objectives
1.2 Market Definition
1.3 Market Scope
1.3.1 Inclusions and Exclusions
1.3.2 Markets Covered & Regional Scope
1.3.3 Years Considered
1.4 Currency
1.5 Limitations
1.6 Summary of Changes

2.1 Key Insights & Market Highlights
2.2 Key Market Participants: Insights & Developments
2.3 Disruptive Trends Shaping Market Growth
2.4 High-Growth Segments & Emerging Frontiers
2.5 Snapshot: Global Market Size, Growth Rate, and Forecast

3.1 Neurovascular Devices Market Overview
3.2 Asia-Pacific: Neurovascular Devices Market, by Type and Country
3.3 Neurovascular Devices Market: Geographical Mix
3.4 Neurovascular Devices Market: Regional Mix
3.5 Neurovascular Devices Market: Developed vs. Emerging Markets

4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Increase in Incidence of Neurovascular Diseases
4.2.1.2 Availability of Medical Reimbursements for Neurovascular Procedures
4.2.1.3 Expansion of Healthcare Infrastructure Across Emerging Economies
4.2.1.4 Rise in Demand for Effective Neurovascular Technologies
4.2.2 Restraints
4.2.2.1 Dearth of Skilled Neurosurgeons
4.2.2.2 High Procedural Cost of Neurovascular Surgeries and Associated Products
4.2.3 Opportunities
4.2.3.1 Advancement of AI- and Robot-Assisted Systems for Next-Generation Neurointerventions
4.2.4 Challenges
4.2.4.1 Stringent Regulatory Approval Process for Medical Devices
4.3 Unmet Needs and White Spaces
4.3.1 Unmet Needs
4.3.2 White Space Opportunities
4.4 Interconnected Markets and Cross-Sector Opportunities
4.4.1 Interconnected Markets
4.4.2 Cross-Sector Opportunities
4.5 Strategic Moves by Tier 1/2/3 Players

5.1 Porter's Five Forces Analysis
5.1.1 Intensity of Competitive Rivalry
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of Substitutes
5.1.5 Threat of New Entrants
5.2 Macroeconomic Outlook
5.2.1 Introduction
5.2.2 GDP Trends and Forecast
5.2.3 Trends in Neurovascular Devices Market
5.3 Supply Chain Analysis
5.4 Value Chain Analysis
5.5 Ecosystem Analysis
5.6 Pricing Analysis
5.6.1 Average Selling Price Trend of Key Players, by Disease Pathology
5.6.2 Average Selling Price Trend of Neurovascular Devices, by Region
5.7 Trade Analysis
5.7.1 Import Data for HS Code 901890, 2020-2024
5.7.2 Export Data for HS Code 901890, 2020-2024
5.8 Key Conferences & Events, 2025-2026
5.9 Trends/Disruptions Impacting Consumers’ Businesses
5.10 Investment & Funding Scenario
5.11 Case Study Analysis
5.11.1 Flow Diverter for Complex Intracranial Aneurysms
5.11.2 Advanced Flow Diverter with Enhanced Deliverability
5.11.3 Stent Retriever Thrombectomy for Acute In-Stent Thrombosis
5.12 Impact of 2025 US Tariffs on Neurovascular Devices Market
5.12.1 Introduction
5.12.2 Key Tariff Rates
5.12.3 Price Impact Analysis
5.12.4 Impact on Countries and Regions
5.12.4.1 US
5.12.4.2 Europe
5.12.4.3 Asia-Pacific
5.12.5 Impact on End-user Industries

6.1 Key Emerging Technologies
6.1.1 Negative Pressure Clot Removal Technology
6.2 Complementary Technologies
6.2.1 Digital Health and Remote Monitoring Platforms
6.3 Technology/Product Roadmap
6.3.1 Short-Term (2025-2027) | Foundation & Early Commercialization
6.3.2 Mid-Term (2027-2030) | Expansion & Standardization
6.3.3 Long-Term (2030-2035+) | Mass Commercialization & Disruption
6.4 Patent Analysis
6.4.1 Patent Publication Trends for Neurovascular Devices Market
6.4.2 Jurisdiction Analysis: Top Applicants for Patents in Neurovascular Devices Market
6.4.3 List of Major Patents
6.5 Impact of AI/Gen AI on Neurovascular Devices Market
6.5.1 Top Use Cases and Market Potential
6.5.2 Top Case Studies of AI Implementation in Neurovascular Devices Market
6.5.3 Interconnected Adjacent Ecosystem and Impact on Market Players
6.5.4 Clients’ Readiness to Adopt Generative AI in Neurovascular Devices Market
6.6 Success Stories and Real-World Applications
6.6.1 Rapid Medical - AI-Powered Robotic Thrombectomy
6.6.2 Aidoc - AI Imaging & Stroke Workflow Acceleration
6.6.3 Rapidai - AI-Driven Neurovascular Imaging

7.1 Regional Regulations and Compliance
7.1.1 Regulatory Bodies, Government Agencies, and Other Organizations
7.1.2 Industry Standards
7.1.2.1 North America
7.1.2.1.1 US
7.1.2.1.2 Canada
7.1.2.2 Europe
7.1.2.3 Asia-Pacific
7.1.2.3.1 China
7.1.2.3.2 Japan
7.1.2.3.3 India
7.1.2.4 Latin America
7.1.2.4.1 Brazil
7.1.2.4.2 Mexico
7.1.2.5 Middle East
7.1.2.6 Africa
7.2 Certifications, Labeling, and Eco-Standards
7.2.1 Certifications, Labeling, and Eco-Standards in Neurovascular Devices Market

8.1 Decision-Making Process
8.2 Buyer Stakeholders and Buying Evaluation Criteria
8.2.1 Key Stakeholders in Buying Process
8.2.2 Key Buying Criteria
8.3 Adoption Barriers & Internal Challenges
8.4 Unmet Needs in End-users
8.5 Market Profitability
8.5.1 Revenue Potential
8.5.2 Cost Dynamics
8.5.3 Margin Opportunities in Key Applications

9.1 Introduction
9.2 Cerebral Aneurysms
9.2.1 Embolic Coils
9.2.2 Bare Detachable Coils
9.2.2.1 Significant Adoption of Bare Detachable Coils by Neurosurgeons for Brain Aneurysm Treatment to Promote Growth
9.2.3 Coated Detachable Coils
9.2.3.1 High Cost of Coated Detachable Coils to Limit Adoption
9.2.4 Flow Diversion Devices
9.2.4.1 Rising R&D Activities to Develop Novel Flow Diversion Devices to Promote Growth
9.2.5 Intracranial Stents
9.2.5.1 Increased Efficacy of Stent-Assisted Coiling for Treatment of Wide-Necked Intracranial Aneurysms to Boost Adoption
9.2.6 Other Devices
9.3 Ischemic Strokes
9.3.1 Clot Retriever Devices
9.3.1.1 Proven Clinical Effectiveness in Treating Large Clots and Increase in Number of Clinical Trials Aimed at Validating Their Use in Ischemic Stroke Treatment to Drive Market
9.3.2 Suction & Aspiration Devices
9.3.2.1 Rapid Commercialization of Technologically Advanced Aspiration Devices for Ischemic Stroke Treatment to Support Market
9.3.3 Vascular Snares
9.3.3.1 Limited Procedural Benefits in Stroke Treatment to Limit Adoption of Vascular Snares
9.3.4 Balloon Catheters
9.3.4.1 Growing Recognition of Benefits Associated with Balloon Catheters to Bolster Demand
9.3.5 Other Devices
9.4 Carotid Artery Stenosis
9.4.1 Carotid Artery Stents
9.4.1.1 Growing Adoption of Carotid Artery Stents for Carotid Intervention Procedures to Support Growth
9.4.2 Embolic Protection Devices
9.4.2.1 Growing Utilization of Distal Filters During Carotid Intervention Procedures to Promote Growth
9.4.3 Balloon Catheters
9.4.3.1 Growing Preference for Balloon Catheters to Improve Efficacy of Carotid Intervention Procedures to Augment Growth
9.5 Arteriovenous Malformation & Fistulas
9.5.1 Liquid Embolic Agents
9.5.1.1 Development of Novel Liquid Embolic Agents Offering High Embolization of Arteriovenous Fistulas to Support Growth
9.5.2 Occlusion Balloon Catheters
9.5.2.1 Growing Utilization of Balloon Catheters for Avm Treatment to Support Growth
9.5.3 Microcatheters
9.5.3.1 Improved Compatibility of Microcatheters with Embolic Agents to Boost Demand
9.6 Other Disease Pathologies

10.1 Introduction
10.2 Hospitals and Ambulatory Surgical Centers
10.2.1 Increasing Volume of Neurovascular Procedures due to Availability of Advanced Equipment to Drive Market
10.3 Specialty Clinics
10.3.1 Increase in Neurovascular Diseases to Drive Market
10.4 Research and Academic Institutes
10.4.1 Increasing Collaborations for Development of Technologically Advanced Neurovascular Devices to Support Market Growth

11.1 Introduction
11.2 North America
11.2.1 Macroeconomic Outlook for North America
11.2.2 US
11.2.2.1 Presence of Established Neurovascular Device Manufacturers to Drive Market
11.2.3 Canada
11.2.3.1 Large Target Pool for Ischemic Stroke Patients to Drive Market
11.3 Europe
11.3.1 Macroeconomic Outlook for Europe
11.3.2 Germany
11.3.2.1 Rising Geriatric Population to Drive Market
11.3.3 France
11.3.3.1 Growing Preference for Minimally Invasive Neurovascular Procedures to Drive Market
11.3.4 UK
11.3.4.1 Rising Prevalence of Stroke to Drive Market
11.3.5 Italy
11.3.5.1 Increasing Geriatric Population to Drive Demand for Neurovascular Devices
11.3.6 Spain
11.3.6.1 Rising Stroke Burden and Strong Healthcare Investment to Drive Demand for Neurovascular Devices Market
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Macroeconomic Outlook for Asia-Pacific
11.4.2 Japan
11.4.2.1 Increase in Healthcare Spending to Drive Market
11.4.3 China
11.4.3.1 Robust Presence of Neurovascular Device Manufacturers to Drive Market
11.4.4 India
11.4.4.1 Increase in Prevalence of Neurovascular Diseases to Drive Uptake for Neurovascular Devices
11.4.5 Australia
11.4.5.1 Rise in Incidence of Cerebrovascular Disease to Drive Market
11.4.6 South Korea
11.4.6.1 Health Insurance Coverage for Neurovascular Procedures to Support Market Growth
11.4.7 Rest of Asia-Pacific
11.5 Latin America
11.5.1 Macroeconomic Outlook for Latin America
11.5.2 Brazil
11.5.2.1 Increasing Awareness Initiatives on Stroke Symptoms to Drive Market
11.5.3 Mexico
11.5.3.1 Increasing Neurovascular Diseases to Support Market Growth
11.5.4 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Macroeconomic Outlook for the Middle East & Africa
11.6.2 Shortage of Neurosurgeons and Poor Healthcare Coverage to Restrain Market Growth
11.6.3 GCC Countries
11.6.3.1 Rising Stroke Prevalence to Drive Neurovascular Devices Market in GCC Countries
11.6.4 Rest of Middle East & Africa

12.1 Introduction
12.2 Key Player Strategies/Right to Win
12.2.1 Overview of Major Strategies Adopted by Key Players in Neurovascular Devices Market
12.3 Revenue Analysis
12.4 Market Share Analysis, 2024
12.5 Company Evaluation Matrix: Key Players, 2024
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2024
12.5.5.1 Company Footprint
12.5.5.2 Regional Footprint
12.5.5.3 Disease Pathology Footprint
12.5.5.4 By End-user Footprint
12.6 Company Evaluation Matrix: Startups/SMEs, 2024
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking: Startups/SMEs, 2024
12.6.5.1 Detailed List of Key Startups/SMEs
12.6.5.2 Competitive Benchmarking of Key Startups/SMEs
12.7 Company Valuation & Financial Metrics
12.7.1 Financial Metrics
12.7.2 Company Valuation
12.8 Brand/Product Comparison
12.9 R&D Expenditure of Key Players
12.10 Competitive Scenario
12.10.1 Product Launches and Approvals
12.10.2 Deals
12.10.3 Expansions
12.10.4 Other Developments

13.1 Key Players
13.1.1 Stryker
13.1.1.1 Business Overview
13.1.1.2 Products Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product Launches & Approvals
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 Analyst's View
13.1.1.4.1 Key Strengths
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses and Competitive Threats
13.1.2 Medtronic
13.1.2.1 Business Overview
13.1.2.2 Products Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Product Launches & Approvals
13.1.2.3.2 Expansions
13.1.2.4 Analyst's View
13.1.2.4.1 Key Strengths
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses and Competitive Threats
13.1.3 Johnson & Johnson
13.1.3.1 Business Overview
13.1.3.2 Products Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product Launches & Approvals
13.1.3.3.2 Other Developments
13.1.3.4 Analyst's View
13.1.3.4.1 Key Strengths
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses and Competitive Threats
13.1.4 Terumo Corporation
13.1.4.1 Business Overview
13.1.4.2 Products Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Product Launches & Approvals
13.1.4.3.2 Deals
13.1.4.3.3 Expansions
13.1.4.3.4 Other Developments
13.1.4.4 Analyst's View
13.1.4.4.1 Key Strengths
13.1.4.4.2 Strategic Choices
13.1.4.4.3 Weaknesses and Competitive Threats
13.1.5 Penumbra, Inc.
13.1.5.1 Business Overview
13.1.5.2 Products Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Product Launches & Approvals
13.1.5.4 Analyst's View
13.1.5.4.1 Key Strengths
13.1.5.4.2 Strategic Choices
13.1.5.4.3 Weaknesses and Competitive Threats
13.1.6 Microport Scientific Corporation
13.1.6.1 Business Overview
13.1.6.2 Products Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product Launches & Approvals
13.1.6.4 Analyst's View
13.1.6.4.1 Key Strengths
13.1.6.4.2 Strategic Choices
13.1.6.4.3 Weaknesses and Competitive Threats
13.1.7 Balt Group
13.1.7.1 Business Overview
13.1.7.2 Products Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Deals
13.1.7.3.2 Expansions
13.1.7.4 Analyst's View
13.1.7.4.1 Key Strengths
13.1.7.4.2 Strategic Choices
13.1.7.4.3 Weaknesses and Competitive Threats
13.1.8 Kaneka Corporation
13.1.8.1 Business Overview
13.1.8.2 Products Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Product Launches & Approvals
13.1.8.3.2 Deals
13.1.8.4 Analyst's View
13.1.8.4.1 Key Strengths
13.1.8.4.2 Strategic Choices
13.1.8.4.3 Weaknesses and Competitive Threats
13.1.9 Phenox GmbH (Wallaby Medical)
13.1.9.1 Business Overview
13.1.9.2 Products Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product Launches & Approvals
13.1.9.4 Analyst's View
13.1.9.4.1 Key Strengths
13.1.9.4.2 Strategic Choices
13.1.9.4.3 Weaknesses and Competitive Threats
13.1.10 Asahi Intecc Co. Ltd.
13.1.10.1 Business Overview
13.1.10.2 Products Offered
13.1.10.3 Recent Developments
13.1.10.3.1 Deals
13.1.10.3.2 Expansions
13.1.10.4 Analyst's View
13.1.10.4.1 Key Strengths
13.1.10.4.2 Strategic Choices
13.1.10.4.3 Weaknesses and Competitive Threats
13.1.11 Achieva Medical (Peijia Medical)
13.1.11.1 Business Overview
13.1.11.2 Products Offered
13.1.11.3 Recent Developments
13.1.11.3.1 Deals
13.1.12 Rapid Medical
13.1.12.1 Business Overview
13.1.12.2 Products Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Product Launches & Approvals
13.1.12.3.2 Deals
13.1.13 Japan Lifeline Co. Ltd.
13.1.13.1 Business Overview
13.1.13.2 Products Offered
13.1.14 Acandis GmbH
13.1.14.1 Business Overview
13.1.14.2 Products Offered
13.1.14.3 Recent Developments
13.1.14.3.1 Expansions
13.1.15 Evasc Medical System Corp
13.1.15.1 Business Overview
13.1.15.2 Products Offered
13.1.15.3 Recent Developments
13.1.15.3.1 Product Launches & Approvals
13.1.15.3.2 Expansions
13.2 Other Key Players
13.2.1 Sensome
13.2.2 Lepu Medical Technology (Beijing) Co. Ltd.
13.2.3 Imperative Care, Inc.
13.2.4 Medikit Co. Ltd.
13.2.5 Zylox-Tonbridge Medical Co. Ltd.
13.3 SMEs/Startups
13.3.1 Neurosafe Medical Co. Ltd.
13.3.2 Luseed Vascular
13.3.3 Neurovasc Technologies, Inc.
13.3.4 Oxfordendovascular
13.3.5 Galaxy Therapeutics

14.1 Research Data
14.1.1 Secondary Data
14.1.1.1 Key Sources of Secondary Data
14.1.1.2 Key Data from Secondary Sources
14.1.2 Primary Data
14.1.2.1 Key Primary Sources
14.1.2.2 Objectives of Primary Research
14.1.2.3 Key Data from Primary Sources
14.1.2.4 Key Industry Insights
14.1.2.5 Breakdown of Primaries
14.2 Market Size Estimation
14.3 Data Triangulation
14.4 Market Share Estimation
14.5 Research Assumptions
14.6 Factor Analysis
14.7 Research Limitations
14.7.1 Scope-Related Limitations
14.7.2 Methodology-Related Limitations
14.8 Risk Assessment
14.9 Methodology-Related Limitations

15.1 Discussion Guide
15.2 Knowledgestore: The Subscription Portal
15.3 Customization Options

Table 1 Standard Currency Conversion Rates
Table 2 Neurovascular Devices Market: Unmet Needs
Table 3 Strategic Moves by Tier 1/2/3 Players
Table 4 Neurovascular Devices Market: Porter's Five Forces
Table 5 GDP Percentage Change, by Key Country, 2021-2030
Table 6 Role in Ecosystem: Neurovascular Devices Market
Table 7 Average Selling Price Trend of Stent Retrievers, by Company, 2023-2025 (USD)
Table 8 Average Selling Price Trend of Carotid Artery Stents, by Company, 2023-2025 (USD)
Table 9 Average Selling Price Trend of Aspiration Devices, by Company, 2023-2025 (USD)
Table 10 Average Selling Price Trend of Microcatheters, by Company, 2023-2025 (USD)
Table 11 Average Selling Price Trend of Balloon Catheters, by Company, 2023-2025 (USD)
Table 12 Average Selling Price Trend of Neurovascular Devices, by Region, 2022-2024 (USD)
Table 13 Import Data for HS Code 901890, by Country, 2020-2024 (USD Thousand)
Table 14 Export Data for HS Code 901890, by Country, 2020-2024 (USD Thousand)
Table 15 Neurovascular Devices Market: Detailed List of Key Conferences & Events, January 2025-December 2026
Table 16 Medtronic: Flow Diverter for Complex Intracranial Aneurysms
Table 17 Phenox: Advanced Flow Diverter with Enhanced Deliverability
Table 18 Stryker: Stent Retriever Thrombectomy for Acute In-Stent Thrombosis
Table 19 US-Adjusted Reciprocal Tariff Rates
Table 20 Neurovascular Devices Market: List of Major Patents, 2022-2025
Table 21 Top Use Cases and Market Potential
Table 22 Neurovascular Devices Market: Case Studies Related to Gen AI Implementation
Table 23 Interconnected Adjacent Ecosystem and Impact on Market Players
Table 24 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 25 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 26 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 27 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 28 Rest of the World: Regulatory Bodies, Government Agencies, and Other Organizations
Table 29 Influence of Stakeholders on Buying Process by Disease Pathology
Table 30 Key Buying Criteria for Top Applications
Table 31 Adoption Barriers & Internal Challenges
Table 32 Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 33 Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 34 Neurovascular Devices Market for Cerebral Aneurysms, by Region, 2023-2030 (USD Million)
Table 35 Embolic Coils Market for Cerebral Aneurysms, by Region, 2023-2030 (USD Million)
Table 36 Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 37 Embolic Coils Market for Cerebral Aneurysms, by Region, 2023-2030 (Thousand Units)
Table 38 Bare Detachable Coils Market for Cerebral Aneurysms, by Region, 2023-2030 (USD Million)
Table 39 Coated Detachable Coils Market for Cerebral Aneurysms, by Region, 2023-2030 (USD Million)
Table 40 Flow Diversion Devices Market for Cerebral Aneurysms, by Region, 2023-2030 (USD Million)
Table 41 Intracranial Stents Market for Cerebral Aneurysms, by Region, 2023-2030 (USD Million)
Table 42 Intracranial Stents Market for Cerebral Aneurysms, by Region, 2023-2030 (Thousand Units)
Table 43 Other Devices Market for Cerebral Aneurysms, by Region, 2023-2030 (USD Million)
Table 44 Neurovascular Devices Market for Ischemic Strokes, by Region, 2023-2030 (USD Million)
Table 45 Neurovascular Devices Market for Ischemic Strokes, by Type 2023-2030 (USD Million)
Table 46 Clot Retriever Devices Market for Ischemic Strokes, by Region, 2023-2030 (USD Million)
Table 47 Clot Retriever Devices Market for Ischemic Strokes, by Region, 2023-2030 (Thousand Units)
Table 48 Suction & Aspiration Devices Market for Ischemic Strokes, by Region, 2023-2030 (USD Million)
Table 49 Vascular Snares Market for Ischemic Strokes, by Region, 2023-2030 (USD Million)
Table 50 Balloon Catheters Market for Ischemic Strokes, by Region, 2023-2030 (USD Million)
Table 51 Other Devices Market for Ischemic Strokes, by Region, 2023-2030 (USD Million)
Table 52 Neurovascular Devices Market for Carotid Artery Stenosis, by Region, 2023-2030 (USD Million)
Table 53 Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 54 Carotid Artery Stents Market for Carotid Artery Stenosis, by Region, 2023-2030 (USD Million)
Table 55 Carotid Artery Stents Market for Carotid Artery Stenosis, by Region, 2023-2030 (Thousand Units)
Table 56 Embolic Protection Devices Market for Carotid Artery Stenosis, by Region, 2023-2030 (USD Million)
Table 57 Balloon Catheters Market for Carotid Artery Stenosis, by Region, 2023-2030 (USD Million)
Table 58 Neurovascular Devices Market for Arteriovenous Malformation & Fistulas, by Region, 2023-2030 (USD Million)
Table 59 Neurovascular Devices Market for Arteriovenous Malformation & Fistulas, by Type, 2023-2030 (USD Million)
Table 60 Liquid Embolic Agents Market for Arteriovenous Malformation & Fistulas, by Region, 2023-2030 (USD Million)
Table 61 Occlusion Balloon Catheters Market for Arteriovenous Malformation & Fistulas, by Region, 2023-2030 (USD Million)
Table 62 Microcatheters Market for Arteriovenous Malformation & Fistulas, by Region, 2023-2030 (USD Million)
Table 63 Neurovascular Devices Market for Other Disease Pathologies, by Region, 2023-2030 (USD Million)
Table 64 Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 65 Neurovascular Devices Market for Hospitals and Ambulatory Surgical Centers, by Region, 2023-2030 (USD Million)
Table 66 Neurovascular Devices Market for Specialty Clinics, by Region, 2023-2030 (USD Million)
Table 67 Neurovascular Devices Market for Research Laboratories and Academic Institutes, by Region, 2023-2030 (USD Million)
Table 68 Neurovascular Devices Market, by Region, 2023-2030 (USD Million)
Table 69 North America: Neurovascular Devices Market, by Country, 2023-2030 (USD Million)
Table 70 North America: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 71 North America: Neurovascular Devices Market for Cerebral Aneurysms, 2023-2030 (USD Million)
Table 72 North America: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 73 North America: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 74 North America: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 75 North America: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 76 North America: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 77 US: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 78 US: Neurovascular Devices Market for Cerebral Aneurysms, 2023-2030 (USD Million)
Table 79 US: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 80 US: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 81 US: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 82 US: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 83 US: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 84 Canada: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 85 Canada: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 86 Canada: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 87 Canada: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 88 Canada: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 89 Canada: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 90 Canada: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 91 Europe: Neurovascular Devices Market, by Country, 2023-2030 (USD Million)
Table 92 Europe: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 93 Europe: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 94 Europe: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 95 Europe: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 96 Europe: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 97 Europe: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 98 Europe: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 99 Germany: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 100 Germany: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 101 Germany: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 102 Germany: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 103 Germany: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 104 Germany: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 105 Germany: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 106 France: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 107 France: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 108 France: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 109 France: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 110 France: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 111 France: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 112 France: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 113 UK: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 114 UK: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 115 UK: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 116 UK: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 117 UK: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 118 UK: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 119 UK: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 120 Italy: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 121 Italy: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 122 Italy: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 123 Italy: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 124 Italy: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 125 Italy: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 126 Italy: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 127 Spain: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 128 Spain: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 129 Spain: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 130 Spain: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 131 Spain: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 132 Spain: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 133 Spain: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 134 Rest of Europe: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 135 Rest of Europe: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 136 Rest of Europe: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 137 Rest of Europe: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 138 Rest of Europe: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 139 Rest of Europe: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 140 Rest of Europe: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 141 Asia-Pacific: Neurovascular Devices Market, by Country, 2023-2030 (USD Million)
Table 142 Asia-Pacific: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 143 Asia-Pacific: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 144 Asia-Pacific: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 145 Asia-Pacific: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 146 Asia-Pacific: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 147 Asia-Pacific: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 148 Asia-Pacific: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 149 Japan: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 150 Japan: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 151 Japan: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 152 Japan: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 153 Japan: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 154 Japan: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 155 Japan: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 156 China: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 157 China: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 158 China: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 159 China: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 160 China: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 161 China: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 162 China: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 163 India: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 164 India: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 165 India: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 166 India: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 167 India: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 168 India: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 169 India: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 170 Australia: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 171 Australia: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 172 Australia: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 173 Australia: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 174 Australia: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 175 Australia: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 176 Australia: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 177 South Korea: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 178 South Korea: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 179 South Korea: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 180 South Korea: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 181 South Korea: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 182 South Korea: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 183 South Korea: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 184 Rest of Asia-Pacific: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 185 Rest of Asia-Pacific: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 186 Rest of Asia-Pacific: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 187 Rest of Asia-Pacific: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 188 Rest of Asia-Pacific: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 189 Rest of Asia-Pacific: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 190 Rest of Asia-Pacific: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 191 Latin America: Neurovascular Devices Market, by Country, 2023-2030 (USD Million)
Table 192 Latin America: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 193 Latin America: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 194 Latin America: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 195 Latin America: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 196 Latin America: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 197 Latin America: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 198 Latin America: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 199 Brazil: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 200 Brazil: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 201 Brazil: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 202 Brazil: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 203 Brazil: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 204 Brazil: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 205 Brazil: Neurovascular Devices Market, by End-user 2023-2030 (USD Million)
Table 206 Mexico: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 207 Mexico: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 208 Mexico: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 209 Mexico: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 210 Mexico: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 211 Mexico: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 212 Mexico: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 213 Rest of Latin America: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 214 Rest of Latin America: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 215 Rest of Latin America: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 216 Rest of Latin America: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 217 Rest of Latin America: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 218 Rest of Latin America: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 219 Rest of Latin America: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 220 Middle East & Africa: Neurovascular Devices Market, by Subregion, 2023-2030 (USD Million)
Table 221 Middle East & Africa: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 222 Middle East & Africa: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 223 Middle East & Africa: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 224 Middle East & Africa: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 225 Middle East & Africa: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 226 Middle East & Africa: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 227 Middle East & Africa: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 228 GCC Countries: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 229 GCC Countries: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 230 GCC Countries: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 231 GCC Countries: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 232 GCC Countries: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 233 GCC Countries: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 234 GCC Countries: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 235 Rest of Middle East & Africa: Neurovascular Devices Market, by Disease Pathology, 2023-2030 (USD Million)
Table 236 Rest of Middle East & Africa: Neurovascular Devices Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 237 Rest of Middle East & Africa: Embolic Coils Market for Cerebral Aneurysms, by Type, 2023-2030 (USD Million)
Table 238 Rest of Middle East & Africa: Neurovascular Devices Market for Ischemic Strokes, by Type, 2023-2030 (USD Million)
Table 239 Rest of Middle East & Africa: Neurovascular Devices Market for Carotid Artery Stenosis, by Type, 2023-2030 (USD Million)
Table 240 Rest of Middle East & Africa: Neurovascular Devices Market for Arteriovenous Malformations and Fistulas, by Type, 2023-2030 (USD Million)
Table 241 Rest of Middle East & Africa: Neurovascular Devices Market, by End-user, 2023-2030 (USD Million)
Table 242 Major Strategies Adopted by Key Players in Neurovascular Devices Market, January 2022-June 2025
Table 243 Neurovascular Device Market: Degree of Competition
Table 244 Neurovascular Devices Market: Regional Footprint, 2024
Table 245 Neurovascular Devices Market: Disease Pathology Footprint, 2024
Table 246 Neurovascular Devices Market: by End-user Footprint
Table 247 Neurovascular Devices Market: Detailed List of Key Startups/SME Players, 2024
Table 248 Neurovascular Devices Market: Competitive Benchmarking of Key Startups/SME Players, by Product Type and Region, 2024
Table 249 Neurovascular Devices Market: Product Launches and Approvals, January 2022-November 2025
Table 250 Neurovascular Devices Market: Deals, January 2022-November 2025
Table 251 Neurovascular Devices Market: Expansions, January 2022-November 2025
Table 252 Neurovascular Devices Market: Other Developments, January 2022-November 2025
Table 253 Stryker: Company Overview
Table 254 Stryker: Products Offered
Table 255 Stryker: Product Launches & Approvals
Table 256 Stryker: Deals
Table 257 Stryker: Expansions
Table 258 Medtronic: Company Overview
Table 259 Medtronic: Products Offered
Table 260 Medtronic: Product Launches & Approvals
Table 261 Medtronic: Expansions
Table 262 Johnson & Johnson: Business Overview
Table 263 Johnson & Johnson: Products Offered
Table 264 Johnson & Johnson: Product Launches & Approvals
Table 265 Johnson & Johnson Services, Inc.: Other Developments
Table 266 Terumo Corporation: Company Overview
Table 267 Terumo Corporation: Products Offered
Table 268 Terumo Corporation: Product Launches & Approvals
Table 269 Terumo Corporation: Deals
Table 270 Terumo Corporation: Expansions
Table 271 Terumo Corporation: Other Developments, January 2022-August 2025
Table 272 Penumbra, Inc.: Company Overview
Table 273 Penumbra, Inc.: Products Offered
Table 274 Penumbra, Inc.: Product Launches & Approvals
Table 275 Microport Scientific Corporation: Company Overview
Table 276 Microport Scientific Corporation: Products Offered
Table 277 Microport Scientific Corporation: Product Launches & Approvals
Table 278 Balt Group: Company Overview
Table 279 Balt Group: Products Offered
Table 280 Balt Group: Deals
Table 281 Balt Group: Expansions
Table 282 Kaneka Corporation: Company Overview
Table 283 Kaneka Corporation: Products Offered
Table 284 Kaneka Corporation: Product Launches & Approvals
Table 285 Kaneka Corporation: Deals
Table 286 Phenox GmbH (Wallaby Medical): Company Overview
Table 287 Phenox GmbH (Wallaby Medical): Products Offered
Table 288 Phenox GmbH (Wallaby Medical): Product Launches & Approvals
Table 289 Asahi Intecc Co. Ltd.: Company Overview
Table 290 Asahi Intecc Co. Ltd.: Products Offered
Table 291 Asahi Intecc Co. Ltd.: Deals
Table 292 Asahi Intecc Co. Ltd.: Expansions
Table 293 Achieva Medical (Peijia Medical): Company Overview
Table 294 Achieva Medical (Peijia Medical): Products Offered
Table 295 Achieva Medical (Peijia Medical): Deals
Table 296 Rapid Medical: Company Overview
Table 297 Rapid Medical: Products Offered
Table 298 Rapid Medical: Product Launches & Approvals
Table 299 Rapid Medical: Deals
Table 300 Japan Lifeline Co. Ltd.: Company Overview
Table 301 Japan Lifeline Co. Ltd.: Products Offered
Table 302 Acandis GmbH: Company Overview
Table 303 Acandis GmbH: Products Offered
Table 304 Acandis GmbH: Expansions
Table 305 Evasc Medical System Corp: Company Overview
Table 306 Evasc Medical System Corp: Products Offered
Table 307 Evasc Medical System Corp: Product Launches & Approvals
Table 308 Evasc Medical System Corp: Expansions
Table 309 Research Assumptions

Figure 1 Markets Covered & Regional Scope
Figure 2 Years Considered
Figure 3 Market Scenario
Figure 4 Neurovascular Devices Market, by Disease Pathology, 2025 vs. 2030 (USD Million)
Figure 5 Major Strategies Adopted by Key Players in Neurovascular Devices Market
Figure 6 Disruptive Trends Impacting Growth of Neurovascular Devices Market
Figure 7 High-Growth Segments & Emerging Frontiers in Neurovascular Devices Market, 2024
Figure 8 Asia-Pacific to Register Highest Growth During Forecast Period
Figure 9 Increase in Number of Diseases Related to Neurological Disorders Such as Cerebral Aneurysms and Strokes to Drive Market Growth
Figure 10 Cerebral Aneurysms Segment Accounted for Highest Market Share in Asia-Pacific
Figure 11 China to Grow at Highest CAGR During Forecast Period
Figure 12 Asia-Pacific to Register Highest Growth Rate During Forecast Period, 2025-2030
Figure 13 Emerging Markets to Register Higher Growth Rates During Forecast Period
Figure 14 Diabetes Care Devices Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Neurovascular Devices Market: Porter's Five Forces Analysis
Figure 16 Neurovascular Devices Market: Supply Chain Analysis
Figure 17 Neurovascular Devices Market: Value Chain Analysis
Figure 18 Neurovascular Devices Market: Role in Ecosystem
Figure 19 Neurovascular Devices Market: Trends/Disruptions Impacting Customers’ Businesses
Figure 20 Neurovascular Devices Market: Funding (USD Million) and Number of Deals, 2019-2023
Figure 21 Top Patent Applicants and Owners (Companies/Institutes) for Neurovascular Devices Market, January 2014-December 2024
Figure 22 Top Patent Applicant Countries for Neurovascular Devices Market, January 2014-December 2024
Figure 23 Influence of Key Stakeholders on Buying Process by Disease Pathology
Figure 24 Key Buying Criteria, by Disease Pathology
Figure 25 Neurovascular Devices Market: Geographic Growth Opportunities
Figure 26 Neurovascular Devices Market: North America Snapshot
Figure 27 Neurovascular Devices Market: Asia-Pacific Snapshot
Figure 28 Revenue Share Analysis of Key Players in Neurovascular Devices Market, 2022-2024 (USD Million)
Figure 29 Market Share Analysis of Key Players in Neurovascular Devices Market, 2024
Figure 30 Neurovascular Devices Market: Company Evaluation Matrix (Key Players), 2024
Figure 31 Neurovascular Devices Market: Company Footprint, 2024
Figure 32 Neurovascular Devices Market: Company Evaluation Matrix (Startups/SMEs), 2024
Figure 33 EV/EBITDA of Key Vendors, 2024
Figure 34 Year-To-Date (YTD) Price Total Return and 5-Year Stock Beta of Key Vendors, 2024
Figure 35 Neurovascular Devices Market: Brand/Product Comparative Analysis
Figure 36 Neurovascular Devices Market: R&D Expenditure of Key Players, 2022-2024
Figure 37 Stryker: Company Snapshot, 2024
Figure 38 Medtronic: Company Snapshot, 2024
Figure 39 Johnson & Johnson: Company Snapshot, 2024
Figure 40 Terumo Corporation: Company Snapshot, 2024
Figure 41 Penumbra, Inc.: Company Snapshot, 2024
Figure 42 Microport Scientific Corporation: Company Snapshot, 2024
Figure 43 Kaneka Corporation: Company Snapshot, 2024
Figure 44 Asahi Intecc Co. Ltd.: Company Snapshot, 2024
Figure 45 Japan Lifeline Co. Ltd.: Company Snapshot, 2024
Figure 46 Research Design
Figure 47 Neurovascular Devices Market: Key Data from Secondary Sources
Figure 48 Neurovascular Devices Market: Key Primary Sources (Demand and Supply Side)
Figure 49 Key Data from Primary Sources
Figure 50 Key Insights from Industry Experts
Figure 51 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 52 Breakdown of Primary Interviews, by End-user, Designation, and Region
Figure 53 Market Size Estimation Process Through Revenue Data
Figure 54 US: Revenue Share Analysis for Stryker, 2024
Figure 55 Supply Side Analysis, 2024
Figure 56 CAGR Projections: Supply-Side Analysis
Figure 57 Bottom-Up Approach
Figure 58 CAGR Projections from Drivers, Restraints, Opportunities, and Challenges Analysis, 2025-2030
Figure 59 Top-Down Approach
Figure 60 Data Triangulation Methodology